Rubix Strategies LLC dba Rubix LS
Rubix LS is the Health Outcomes Architect Company, dedicated to designing transformative health solutions for every community. They focus on holistic, precision-focused approaches that address biological, environmental, and socioeconomic factors affecting health. Their mission is to create a healthier future by improving health outcomes, especially for underserved populations, through innovative research, data-driven insights, and inclusive healthcare strategies.
Industries
Nr. of Employees
small (1-50)
Rubix Strategies LLC dba Rubix LS
Lawrence, Massachusetts, United States, North America
Products
Large clinical data repository (multi‑million records)
A centrally managed, diverse clinical dataset containing over 12 million patient records to support cohort identification, epidemiology, and RWE analyses.
AI analytics and knowledge platform for drug development
A dual consulting and technology platform combining scientific AI analytics and curated data libraries to accelerate hit confirmation, lead optimization, and preclinical assessment.
Large clinical data repository (multi‑million records)
A centrally managed, diverse clinical dataset containing over 12 million patient records to support cohort identification, epidemiology, and RWE analyses.
AI analytics and knowledge platform for drug development
A dual consulting and technology platform combining scientific AI analytics and curated data libraries to accelerate hit confirmation, lead optimization, and preclinical assessment.
Services
End-to-end contract research services (CRO)
Delivery of comprehensive clinical research services including protocol development, site operations, regulatory planning, and Phase I–II execution with emphasis on inclusivity and scale.
Data analytics and RWE generation
AI-driven analytics services for genomic, clinical, and real-world datasets to inform trial design, variant interpretation, and treatment stratification.
Investigator‑led research support
Operational, data, and methodological support for investigator-initiated studies, with emphasis on underserved populations and health equity.
Federal collaboration and public health programs
Partnerships and contract research services tailored to federal agencies and public health initiatives, providing rapid, cross-disciplinary research support.
Regulatory and protocol consulting
Early-stage regulatory planning, pre-IND guidance, and alignment with global regulatory requirements to reduce filing risk and accelerate approvals.
Stem cell and regenerative medicine trial consulting
Consulting services covering trial design, dosing and endpoint selection, safety monitoring, and regulatory considerations specific to cellular therapies.
End-to-end contract research services (CRO)
Delivery of comprehensive clinical research services including protocol development, site operations, regulatory planning, and Phase I–II execution with emphasis on inclusivity and scale.
Data analytics and RWE generation
AI-driven analytics services for genomic, clinical, and real-world datasets to inform trial design, variant interpretation, and treatment stratification.
Investigator‑led research support
Operational, data, and methodological support for investigator-initiated studies, with emphasis on underserved populations and health equity.
Federal collaboration and public health programs
Partnerships and contract research services tailored to federal agencies and public health initiatives, providing rapid, cross-disciplinary research support.
Regulatory and protocol consulting
Early-stage regulatory planning, pre-IND guidance, and alignment with global regulatory requirements to reduce filing risk and accelerate approvals.
Stem cell and regenerative medicine trial consulting
Consulting services covering trial design, dosing and endpoint selection, safety monitoring, and regulatory considerations specific to cellular therapies.
Expertise Areas
- Clinical trial management
- Decentralized and adaptive trial design
- Clinical data analytics and real-world evidence
- Biomarker and genomic analysis
Key Technologies
- Generative AI for genomic analysis
- Machine learning for predictive recruitment
- Real-world evidence analytics
- Secure clinical data infrastructure (21 CFR Part 11 / CDISC-aligned)